Article Text

Download PDFPDF
Prognostic value of weight loss in patients with amyotrophic lateral sclerosis
  1. Frederik J Steyn1,2,
  2. Shyuan T Ngo2,3
  1. 1 Faculty of Medicine, The University of Queensland, Saint Lucia, Queensland, Australia
  2. 2 Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
  3. 3 The Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Saint Lucia, Queensland, Australia
  1. Correspondence to Dr Frederik J Steyn, Faculty of Medicine, The University of Queensland, Saint Lucia, QLD 4072, Australia; f.steyn{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Improved patient outcomes may come from a greater understanding of the cause for prediagnostic weight loss in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is an insidious disease. Diagnosis is made following observation of functional deficits that occur due to the death of upper and lower motor neurons. Pathological hallmarks of corticospinal tract involvement are almost always present, whereas upper motor neuron involvement could be subclinical.1 This complex clinicopathological phenotype is now recognised within a wide spectrum of disease that may include extramotor features such as cognitive and behavioural impairments.1 While median survival is currently 3 years following symptom onset, survival could become much longer. Superimposed on this elaborate canvas of presentation and progression is a range of factors thought to impact survival. Van Mantgem and colleagues …

View Full Text


  • Twitter @Fred_Steyn, @NgoShyuan

  • Contributors Both authors take full responsibility for the integrity and accuracy of information presented. They were also involved in drafting of the manuscript.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles